Skip to content

The effect of repetitive transcranial magnetic stimulation for Parkinson's Disease of motor and nonmotor symptoms

The effect of repetitive transcranial magnetic stimulation for Parkinson's Disease of motor and nonmotor symptoms: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039557
Enrollment
Unknown
Registered
2020-10-31
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

contral group:repetitive transcranial magnetic stimulation with sham coil

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Idiopathic Parkinson's Disease and diagnosed according to the 2015 Movement Disorder Society (MDS) clinical diagnostic criteria; 2. One or more situation as follow: have 1 or more pain with the VAS more than 3 and last at least 3 month; have one or more kind of sleep disorder; have freezing gait; 3. Patients with stable anti parkinsonian therapy for >= 2 weeks, and stay on their medication regimens throughout the trial; 4. Patients with stable non steroidal anti-inflammatory drugs and other analgesic drugs therapy for >= 16 weeks, and stay on their medication regimens throughout the trial; 5. The brain CT/MRI has no special change; 6. Patients with Mini–Mental State Examination scores > 22; 7. Patients and their families who sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with conditions other than PD that can cause pain, such as diabetes, herpes infection, long-term special drugs or heavy drinking, stroke, spinal cord disease; 2. Patients with severe depression or mental disorders; 3. Patients with histories of intracranial organic lesions or traumatic brain injury; 4. Patients with severe organic diseases such as heart, liver and kidney; 5. Patients with claustrophobia, implantable devices such as pacemaker, history of epilepsy, who can not complete MRI examination or receive rTMS treatment.

Design outcomes

Primary

MeasureTime frame
numerical rating scale;polysomnography;Resting-state brain functional MRI;

Secondary

MeasureTime frame
King's Parkinson's Pain Scale;

Countries

China

Contacts

Public ContactChunfeng Liu

The Second Affiliated Hospital of Soochow University

liuchunfeng@suda.edu.cn+86 13606210609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026